A- A A+

Associations amongst form of cocaine used (powder vs crack vs both) and HIV-related outcomes. 

Liu Y, Richards VL, Gebru NM, Spencer EC, Cook RL. 

Addict Behav Rep. 2021 Sep 4;14:100374. doi: 10.1016/j.abrep.2021.100374. PMID: 34938835; PMCID: PMC8664776.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664776/

Injection drug use practices and HIV infection among people who inject drugs in Kigali, Rwanda: a cross-sectional study.

Twahirwa Rwema JO, Nizeyimana V, Prata NM, Okonkwo NE, Mazzei AA, Muhirwa S, Rukundo A, Lucas L, Niyigena A, Makuza JD, Beyrer C, Baral SD, Kagaba A. 

Harm Reduct J. 2021 Dec 15;18(1):130. doi: 10.1186/s12954-021-00579-0. PMID: 34911554; PMCID: PMC8672501.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8672501/

Prevalence of HIV, Hepatitis C and its related risk behaviours among women who inject drugs in the Kathmandu Valley, Nepal: a cross-sectional study. 

Damas J, Storm M, Pandey LR, Marrone G, Deuba K. 

Ther Adv Infect Dis. 2021 Dec 3;8:20499361211062107. doi: 10.1177/20499361211062107. PMID: 34881024; PMCID: PMC8646840.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646840/

INPUD Summary Report: WHO Key Populations' Values & Preferences for HIV, Hepatitis and STIs Services 

Introduction

Over the last several months INPUD has collaborated with the World Health Organization (WHO) Department for Global HIV, Hepatitis and STI Programmes on a global qualitative study examining the values and preferences of key populations, including people who inject drugs, for HIV, Hepatitis and STIs services. The findings of this study will inform the update of the WHO 2016 Consolidated Guidelines for HIV prevention, diagnosis, treatment and care for key populations. These Guidelines will be used to inform countries on the design and implementation of health packages for key populations, making it extremely important that they take into account the specific values and preferences of each key population included in the study (people who inject drugs, gay and bisexual men and other men who have sex with men, female, male and trans sex workers and trans people). (INPUD - The International Network of People who Use Drugs, 2021)

https://www.inpud.net/sites/default/files/INPUD%20Summary%20Report%20WHO%20V%26P%20Study.pdf

Costs and impact on HIV transmission of a switch from a criminalisation to a public health approach to injecting drug use in eastern Europe and central Asia: a modelling analysis

Ward, Zoe et al.

The Lancet HIV, Volume 0, Issue 0 

https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(21)00274-5/fulltext

"That same stigma...that same hatred and negativity:" a qualitative study to understand stigma and medical mistrust experienced by people living with HIV diagnosed with COVID-19. 

Hall A, Joseph O, Devlin S, Kerman J, Schmitt J, Ridgway JP, McNulty MC. 

BMC Infect Dis. 2021 Oct 14;21(1):1066. doi: 10.1186/s12879-021-06693-5. PMID: 34649501; PMCID: PMC8515148.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8515148/

"It's a burden, it's a nuisance. I wish I didn't have these other ailments": a qualitative exploration of comorbidities management among older people living with HIV who use drugs in Vancouver, British Columbia. 

Chayama KL, Ng C, Small W, Ivsins A, McNeil R. 

J Int AIDS Soc. 2021 Oct;24(10):e25785. doi: 10.1002/jia2.25785. PMID: 34636148; PMCID: PMC8505831.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505831/

PrEP Care Continuum Engagement Among Persons Who Inject Drugs: Rural and Urban Differences in Stigma and Social Infrastructure. 

Walters SM, Frank D, Van Ham B, Jaiswal J, Muncan B, Earnshaw V, Schneider J, Friedman SR, Ompad DC. 

AIDS Behav. 2021 Oct 9:1–13. doi: 10.1007/s10461-021-03488-2. Epub ahead of print. PMID: 34626265; PMCID: PMC8501360.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8501360/

Design and implementation of a cohort study of persons living with HIV infection who are initiating medication treatment for opioid use disorder to evaluate HIV-1 persistence. 

Schultheis A, Sanchez M, Pedersen S, Kyriakides T, Ho YC, Kluger Y, Springer SA. 

Contemp Clin Trials Commun. 2021 Nov 11;24:100866. doi: 10.1016/j.conctc.2021.100866. PMID: 34825103; PMCID: PMC8605182.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8605182/

Prevalence, beliefs and impact of drug-drug interactions between antiretroviral therapy and illicit drugs among people living with HIV in Spain. 

Castro-Granell V, Garin N, Jaén Á, Cenoz S, Galindo MJ, Fuster-RuizdeApodaca MJ. 

PLoS One. 2021 Nov 19;16(11):e0260334. doi: 10.1371/journal.pone.0260334. PMID: 34797882; PMCID: PMC8604370.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604370/

HIV/Aids: Erste Ziele erreicht

Dtsch Arztebl 2021; 118(48): A-2264 / B-1863

Hillienhof, Arne

Deutschland hat im vergangenen Jahr erstmals das „90–90–90-Ziel“ des gemeinsamen Programms der Vereinten Nationen gegen HIV/Aids (UNAIDS) erreicht. Zu tun gibt es dennoch weiterhin viel.

https://www.aerzteblatt.de/archiv/222315

Victories against AIDS have lessons for COVID-19

Anthony Fauci on four decades of progress against HIV, and what’s needed for the future. (Nature, USA, 29.11.2021)

https://www.nature.com/articles/d41586-021-03569-1

USA. Nora's Blog: This World AIDS Day, Finding Inspiration at the Intersection of HIV and Substance Use 

Today marks the 33rd  World AIDS Day. As we work to address the structural and social challenges that prevent many people from accessing both essential HIV services and addiction treatment, the HIV and addiction fields can learn from one another. Researchers, clinicians, and activists living and working at the intersection of HIV and substance use can shed light on reaching the most vulnerable groups with tailored, compassionate and quality care. This is crucial in ensuring that our national HIV response encompasses interventions that address the complex interactions between substance misuse and HIV. (NIH – National Institute of Health, USA, 01.12.2021)

https://www.drugabuse.gov/about-nida/noras-blog/2021/12/world-aids-day-finding-inspiration-intersection-hiv-substance-use

Evaluation of an Inner city HIV pre-exposure prophylaxis service tailored to the needs of people who inject drugs. 

Grimshaw C, Boyd L, Smith M, Estcourt CS, Metcalfe R. Evaluation 

HIV Med. 2021 Nov;22(10):965-970. doi: 10.1111/hiv.13181. Epub 2021 Sep 28. PMID: 34585494.

https://www.medscape.com/viewarticle/961563

USA. Florida is the epicenter of the nation's HIV and opioid crises. This doctor is battling to stop the virus and winning. 

(…) In less than 20 months, Tookes’ hybrid needle exchange telehealth and HIV medication outreach program has become the most successful HIV suppression campaign in the nation. Of the 35 patients treated as part of the pilot, 78.1% were undetectable within six months, which means patients cannot transmit the virus to others and the virus does not appear in routine bloodwork. 

The pilot will soon be expanded to 240 people receiving similar treatment.

Part of the program's innovation is that it offers unhoused people the option of connecting with Tookes through iPads anywhere in the city and having medicines delivered. Tookes’ patients are mostly people of color and people experiencing homelessness, two groups that suffer from disproportionately high rates of drug use and HIV. (USA Today, USA, 15.11.2021)

https://eu.usatoday.com/story/news/nation/2021/11/15/hiv-transmission-doctors-mission-his-unique-plan-pays-off/6238356001/

A Possible Sterilizing Cure of HIV-1 Infection Without Stem Cell Transplantation.

Gabriela Turk, Kyra Seiger, Xiaodong Lian, et al. 

Ann Intern Med. [Epub ahead of print 16 November 2021]. doi:10.7326/L21-0297

Abstract

https://www.acpjournals.org/doi/10.7326/L21-0297

Risk of severe clinical events after sustained virological response following direct-acting antiviral therapy in HIV and hepatitis C virus coinfected participants. 

Chalouni M, Wittkop L, Bani-Sadr F, Lacombe K, Esterle L, Gilbert C, Miailhes P, Zucman D, Valantin MA, Brégigeon-Ronot S, Morlat P, Billaud E, Piroth L, Naqvi A, Sogni P, Salmon D; ANRS CO13 HEPAVIH Cohort Study Group. 

HIV Med. 2021 Oct;22(9):791-804. doi: 10.1111/hiv.13127. Epub 2021 Jul 1. PMID: 34212476.

https://www.medscape.com/viewarticle/959827

Methamphetamine use and HIV risk behavior among men who inject drugs: causal inference using coarsened exact matching. 

Noroozi M, Higgs P, Noroozi A, Armoon B, Mousavi B, Alikhani R, Bazrafshan MR, Astaneh AN, Bayani A, Moghaddam LF. 

Harm Reduct J. 2020 Sep 21;17(1):66. doi: 10.1186/s12954-020-00411-1. PMID: 32957982; PMCID: PMC7507738.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7507738/

De novo electrocardiographic abnormalities in persons living with HIV. 

Knudsen AD, Graff C, Nielsen JB, Thomsen MT, Høgh J, Benfield T, Gerstoft J, Køber L, Kofoed KF, Nielsen SD. 

Sci Rep. 2021 Oct 21;11(1):20750. doi: 10.1038/s41598-021-00290-x. PMID: 34675281; PMCID: PMC8531322.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531322/

Perspectives of clients and providers on factors influencing opioid agonist treatment uptake among HIV-positive people who use drugs in Indonesia, Ukraine, and Vietnam: HPTN 074 study. 

Kiriazova T, Go VF, Hershow RB, Hamilton EL, Sarasvita R, Bui Q, Lancaster KE, Dumchev K, Hoffman IF, Miller WC, Latkin CA. 

Harm Reduct J. 2020 Oct 1;17(1):69. doi: 10.1186/s12954-020-00415-x. PMID: 32998731; PMCID: PMC7528574.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7528574/

Could the 2010 HIV outbreak in Athens, Greece have been prevented? A mathematical modeling study. 

Gountas I, Nikolopoulos G, Touloumi G, Fotiou A, Souliotis K (2021)

PLoS ONE 16(10): e0258267. doi.org/10.1371/journal.pone.0258267

https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0258267

Modelling the impact of HIV and HCV prevention and treatment interventions for people who inject drugs in Dar es Salaam, Tanzania. 

Fraser H, Stone J, Wisse E, Sambu V, Mfisi P, Duran IJ, Soriano MA, Walker JG, Makere N, Luhmann N, Kafura W, Nouvellet M, Ragi A, Mundia B, Vickerman P. 

J Int AIDS Soc. 2021 Oct;24(10):e25817. doi: 10.1002/jia2.25817. PMID: 34661964; PMCID: PMC8522890.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522890/

Kampagnenstart: „Leben mit HIV. Anders als du denkst.“ 

BZgA, DAS und DAH starten anlässlich des Welt-Aids-Tages gemeinsame Kampagne gegen Diskriminierung von Menschen mit HIV-Infektion. (BZgA, Deutsche AIDS-Stiftung (DAS) und Deutsche Aidshilfe (DAH), 04.11.2021)

https://www.welt-aids-tag.de/kampagne/

HIV Infection and HIV-Associated Behaviors Among Persons Who Inject Drugs - 23 Metropolitan Statistical Areas, United States, 2018. 

Handanagic S, Finlayson T, Burnett JC, Broz D, Wejnert C; National HIV Behavioral Surveillance Study Group. 

MMWR Morb Mortal Wkly Rep. 2021 Oct 22;70(42):1459-1465. doi: 10.15585/mmwr.mm7042a1. PMID: 34673746.

https://www.cdc.gov/mmwr/volumes/70/wr/mm7042a1.htm?s_cid=mm7042a1_w

Syringe Services Programs' Role in Ending the HIV Epidemic in the U.S.: Why We Cannot Do It Without Them. 

Broz D, Carnes N, Chapin-Bardales J, Des Jarlais DC, Handanagic S, Jones CM, McClung RP, Asher AK. 

Am J Prev Med. 2021 Nov;61(5 Suppl 1):S118-S129. doi: 10.1016/j.amepre.2021.05.044. PMID: 34686281.

https://www.ajpmonline.org/article/S0749-3797(21)00389-5/fulltext

"With a PICC line, you never miss": The role of peripherally inserted central catheters in hospital care for people living with HIV/HCV who use drugs. 

Guta A, Perri M, Strike C, Gagnon M, Carusone SC. 

Int J Drug Policy. 2021 Sep 27:103438. doi: 10.1016/j.drugpo.2021.103438. Epub ahead of print. PMID: 34593288.

https://www.sciencedirect.com/science/article/pii/S0955395921003431

HIV-Epidemiologie in Deutschland: Späte Diagnostik

Dtsch Arztebl 2021; 118(43): A-1994 / B-1644

Valbert, Frederik; Wolf, Eva; Preis, Stefan; Schewe, Knud; Hanhoff, Nikola; Mück, Birgit; Lauscher, Paul; Rüsenberg, Robin; Wasem, Jürgen; Schellberg, Sven; Neumann, Anja

https://www.aerzteblatt.de/archiv/221760

More evidence for worse COVID-19 outcomes in people with HIV

Boffito, Marta et al.

The Lancet HIV, Volume 0, Issue 0 

https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(21)00272-1/fulltext

Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study

Nomah, Daniel KMuntada, Esteve et al.

The Lancet HIV, Volume 0, Issue 0 

https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(21)00240-X/fulltext

Associations between HIV infection and clinical spectrum of COVID-19: a population level analysis based on US National COVID Cohort Collaborative (N3C) data

Yang, XueyingMoffitt, Richard et al.

The Lancet HIV, Volume 0, Issue 0 

https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(21)00239-3/fulltext